The most effective approach considers the full health context, including hormone changes, chronic fatigue, or metabolic issues, rather than applying one-size-fits-all thresholds
Therefore, researchers are recommending that all CKCSs be genetically tested for a specific mutation of the ACADM gene which causes the MCAD deficiency, before including MCTs in their diets
Liraglutide has a half-life of 13h, and reaches brain tissue on crossing the blood brain barrier
This question requires a thoughtful, individualized answer because every chronic condition is different
Baird D, Dunson D et al
Monitoring should include periodic blood chemistries, vital signs, plasma carnitine concentrations, and overall clinical condition